Cargando…

Low Paraoxonase 1 Arylesterase Activity and High von Willebrand Factor Levels are Associated with Severe Coronary Atherosclerosis in Patients with Non-Diabetic Stable Coronary Artery Disease

BACKGROUND: Paraoxonase 1 (PON1) activity and von Willebrand factor (VWF) release are associated with lesion initiation in atherosclerosis. Diabetes can complicate coronary artery disease (CAD) due to the production of advanced glycation end products. This study evaluated PON1 activity and VWF level...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Jieying, Chen, Qizhi, Zhuang, Xing, Feng, Zhilei, Xu, Lili, Chen, Fuxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2014
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254670/ https://www.ncbi.nlm.nih.gov/pubmed/25420483 http://dx.doi.org/10.12659/MSM.890911

Ejemplares similares

Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis
por: Zuin, Marco, et al.
Publicado: (2022)

Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients
por: Erdem, Fazile Hatipoglu, et al.
Publicado: (2010)

Paraoxonase and Arylesterase Activities in Dipper and Non-Dipper Prehypertensive Subjects
por: Yuksel, Murat, et al.
Publicado: (2015)

Paraoxonase/Arylesterase Activity of Serum Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis
por: Zinellu, Angelo, et al.
Publicado: (2023)

Endothelial Lipase Modulates Paraoxonase 1 Content and Arylesterase Activity of HDL
por: Schilcher, Irene, et al.
Publicado: (2021)

Association between brain-derived neurotrophic factor and von Willebrand factor levels in patients with stable coronary artery disease
por: Jin, Hong, et al.
Publicado: (2018)

Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population
por: Elkiran, Emin T, et al.
Publicado: (2007)

Serum Paraoxonase/Arylesterase Activity and Oxidative Stress Status in Children with Metabolic Syndrome
por: Eren, Erdal, et al.
Publicado: (2014)

Usefulness of the Measurement of Serum Paraoxonase-1 Arylesterase Activity in the Diagnoses of COVID-19
por: Gabaldó, Xavier, et al.
Publicado: (2022)

Paraoxonase-1 and Simvastatin Treatment in Patients with Stable Coronary Artery Disease
por: Januszek, Rafał
Publicado: (2016)

Paraoxonase and Arylesterase Activities, Lipid Profile, and Oxidative Damage in Experimental Ischemic Colitis Model
por: Unal, Ethem, et al.
Publicado: (2012)

The Effect of Date Seed (Phoenix dactylifera) Extract on Paraoxonase and Arylesterase Activities in Hypercholesterolemic Rats
por: Takaeidi, Mohammad Reza, et al.
Publicado: (2014)

Evaluation of Paraoxonase, Arylesterase, and Homocysteine Thiolactonase Activities in Patients with Diabetes and Incipient Diabetes Nephropathy
por: Ayan, Durmuş, et al.
Publicado: (2019)

Impact of von Willebrand factor on coronary plaque burden in coronary artery disease patients treated with statins
por: Kato, Yuta, et al.
Publicado: (2018)

Porcine and Canine von Willebrand Factor and von Willebrand Disease: Hemostasis, Thrombosis, and Atherosclerosis Studies
por: Nichols, Timothy C., et al.
Publicado: (2010)

Total Oxidant Status, Total Antioxidant Status, and Paraoxonase and Arylesterase Activities during Laparoscopic Cholecystectomy
por: Koksal, Hande, et al.
Publicado: (2010)

Lipid associated antioxidants: arylesterase and paraoxonase-1 in benign prostatic hyperplasia treatment-naïve patients
por: Asare, George Awuku, et al.
Publicado: (2018)

Serum Paraoxonase, Arylesterase, and Glutathione-S-Transferase Activities and Oxidative Stress Levels in Patients with Mushroom Poisoning
por: Eren, Sevki Hakan, et al.
Publicado: (2018)

Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer’s Disease and Vascular Dementia
por: Romani, Arianna, et al.
Publicado: (2020)

Paraoxonase 1 Activity, Polymorphism and Atherosclerosis Risk Factors in Patients Undergoing Coronary Artery Surgery
por: Wysocka, Anna, et al.
Publicado: (2019)

Evaluation of Paraoxonase, Arylesterase and Malondialdehyde Levels in Schizophrenia Patients Taking Typical, Atypical and Combined Antipsychotic Treatment
por: Güneş, Mehmet, et al.
Publicado: (2016)

von Willebrand Factor and Oxidative Stress Parameters in Acute Coronary Syndromes
por: Koprivica, Zoran, et al.
Publicado: (2011)

Association between inflammatory markers and serum paraoxonase and arylesterase activities in the general population: a cross-sectional study
por: Meisinger, Christa, et al.
Publicado: (2021)

Paraoxonase and arylesterase activity of serum PON-1 enzyme in psoriatic patients: a systematic review and meta-analysis
por: Bassu, Stefania, et al.
Publicado: (2022)

Platelet Adhesion Mediated by von Willebrand Factor at High Shear Rates Is Associated with Premature Coronary Artery Disease
por: Okhota, Sergey, et al.
Publicado: (2023)

Hemophilia and von Willebrand disease: Factor VIII and von Willebrand factor
por: Sharma, Prashant
Publicado: (2019)

Paraoxonase 1 and atherosclerosis
por: Durrington, Paul N., et al.
Publicado: (2023)

Vitamin B6 Supplementation Improves Oxidative Stress and Enhances Serum Paraoxonase/Arylesterase Activities in Streptozotocin-Induced Diabetic Rats
por: Taş, Sibel, et al.
Publicado: (2014)

Relationship between Paraoxonase-1 and Arylesterase Enzyme Activities and SYNTAX I and II Scores in Patients with ST-Elevation Myocardial Infarction
por: Sökmen, Erdoğan, et al.
Publicado: (2019)

Association between Paraoxonase/Arylesterase Activity of Serum PON-1 Enzyme and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Erre, Gian Luca, et al.
Publicado: (2022)

Paraoxonase 3: Structure and Its Role in Pathophysiology of Coronary Artery Disease
por: Priyanka, Kumari, et al.
Publicado: (2019)

Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease
por: Casonato, Alessandra, et al.
Publicado: (2016)

Elevated Plasma von Willebrand Factor Antigen and Activity Levels Are Associated With the Severity of Coronary Stenosis
por: Yan, Bin, et al.
Publicado: (2020)

Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock—A Prospective Pilot Study
por: Reisinger, Alexander C., et al.
Publicado: (2020)

Changes of von Willebrand Factor during Pregnancy in Women with and without von Willebrand Disease
por: Castaman, Giancarlo
Publicado: (2013)

Genetic Variation in the von Willebrand Factor Gene in Swedish von Willebrand Disease Patients
por: Manderstedt, Eric, et al.
Publicado: (2018)

Coronary artery fistula and premature coronary atherosclerosis
por: Turek, Łukasz, et al.
Publicado: (2019)

High Prevalence of Low Serum Paraoxonase-1 in Subjects with Coronary Artery Disease
por: Jayakumari, Narayani, et al.
Publicado: (2009)

Reduced Paraoxonase 1 Activity as a Marker for Severe Coronary Artery Disease
por: Zhou, Chiyan, et al.
Publicado: (2013)

Exploring the Role of Paraoxonases in the Pathogenesis of Coronary Artery Disease: A Systematic Review
por: Abelló, David, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dll60cals50tavetjm644ol64i